Stock CTLT CATALENT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Catalent, Inc.

Equities

CTLT

US1488061029

Real-time Estimate Cboe BZX
Other stock markets
 16:18:16 28/06/2024 BST 		5-day change 1st Jan Change
56.28 USD -0.23% Intraday chart for Catalent, Inc. -0.23% +25.46%
06-27 Barclays Adjusts Catalent Price Target to $63 From $47 MT
06-24 Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing RE

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman
RE
Catalent, Inc. Announces Executive Changes
CI
Activist investor Elliott targets drugmaker BioMarin -sources
RE
Catalent, Inc. Appoints David McErlane as Group President of Catalent?s Biologics segment, Effective September 25, 2023
CI
Catalent, Inc. Appoints Steven Barg as A Member of the Board of Directors
CI
Catalent Director Greisch Buys 21,000 Shares for $1.1 Million
MT
Catalent Discloses Cooperation Deal With Elliot Investment, Offers Upbeat Fiscal 2024 Revenue Guidance
MT
Catalent, Inc. Announces Board Changes
CI
Catalent, Inc. Announces Board Changes
CI
Catalent to settle with Elliott, explore options -sources
RE
Catalent, Inc. Announces Executive Changes
CI
MOVES-Morgan Stanley hires healthcare services banker Cohen from Truist
RE
Catalent Appoints Matti Masanovich as Chief Financial Officer
MT
Catalent names Matti Masanovich as finance head
RE
Catalent, Inc. Appoints Matti Masanovich as Senior Vice President, Effective July 5, 2023
CI
Catalent Expects Productivity Issues, Costs to Hurt Q3 Results; Interim CFO Named; Shares Tumble 27%
MT
Catalent Expects Productivity Issues, Higher Costs to Impact Fiscal Q3 Results; Names Ricky Hopson Interim CFO
MT
Catalent, Inc. Announces Departure of Thomas Castellano as Senior Vice President
CI
Catalent Appoints Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary
CI
Catalent, Inc. Announces the Appointment of Ricardo Zayas as Senior Vice President, Operations, Biologics North America
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTLT Stock
  4. News Catalent, Inc.
  5. Insiders